Journal Guide

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Reports of Practical Oncology and Radiotherapy is an interdisciplinary bimonthly journal, publishing original contributions in clinical oncology and radiotherapy, as well as in radiotherapy physics, techniques and radiotherapy equipment.Reports of Practical Oncology and Radiotherapy is a journal of the Polish Society of Radiation Oncology, the Czech Society of Radiation Oncology, the Hungarian Society for Radiation Oncology, the Slovenian Society for Radiotherapy and Oncology, the Polish Study Group of Head and Neck Cancer, the Guild of Bulgarian Radiotherapists and the Greater Poland Cancer Centre, affiliated with the Spanish Society of Radiotherapy and Oncology, the Portuguese Society of Radiotherapy–Oncology, the Romanian Society of Radiotherapy and Medical Oncology, the Latin American Association for Radiation Oncology and the Grupo Oncólogico Catalan Occitano.Wersja pierwotna czasopisma jest wersja internetowa.

The Revista Colombiana de Cancerología is the official journal of the Instituto Nacional de Cancerología de Colombia (INC), published quarterly, with the aim of widening interest in, and knowledge of, issues on cancer. The Journal publishes articles on molecular carcinogenesis and treatment response, cancer epidemiology, clinical characteristics and treatment of neoplastic illnesses, and on public health programs for the control of cancer.

Los campos de interés de la Revista de Senología y Patología Mamaria incluyen todos aquellos que posibilitan un enfoque multidisciplinar en el diagnóstico y en el tratamiento en la Senología y la Patología Mamaria, tanto en su vertiente investigadora clínica o translacional, como en la educativa. Se promoverá la publicación de manuscritos que integren las áreas de conocimiento de Anatomía Patológica, Cirugía, Epidemiología y Salud Pública, Ginecología, Medicina Nuclear, Oncología Médica, Psicología, Oncología Radioterápica y Radiología.

Revista de Senología y Patología Mamaria aims primarily to publish important scientific studies and educational material in Spanish or English related to the disciplines involved in the study and treatment of breast disease. Likewise, the journal aims to report consensus initiatives and scientific debates in Senology and Breast Pathology.

The journal's fields of interest include all areas that contribute to a multidisciplinary approach to the diagnosis and treatment of breast disease, both in clinical or translational research and in education. The journal promotes the publication of manuscripts on the topics of Pathology, Surgery, Epidemiology and Public Health, Gynecology, Nuclear Medicine, Medical Oncology, Psychology, Radiation Oncology, and Radiology.

Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi's sarcoma, are published as well as preclinical and animal studies.This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients. It is of interest to all those working with bone and soft tissue tumours, including medical, surgical and paediatric oncologists, radiotherapists, pathologists and research scientists.

Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.Topics covered in earlier issues include:• Tumour suppressor genes• Protein kinases in signal transduction• Steroids and their receptors• Transgenic mice in cancer research• Apoptosis and Cancer• RNA interference in cancer biology and treatment• Oncogenes as therapeutic targetsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Oncology brings you current, authoritative, and practical reviews of developments in the diagnosis and management of patients with cancer. Each issue examines a single topic of clinical importance. You're guided through each cancer's biology, epidemiology, and pathophysiology, its clinical presentation and therapeutic options, and appropriate follow-up measures. This journal makes an excellent addition to every oncology practice.2013 Topics: Volume 40The Evolving Landscape of Neuroendocrine TumorsEmily K. BergslandCardio-oncology: The Relationships Between the Heart and CancerMarc L. SchwartzProstate CancerLeonard Gomella, Adam Dicker, and William Kevin KellyRenal CancerBrian I. Rini and Thomas PowlesMultiple MyelomaAndrzej J. JakubowiakLung CancerDavid CarboneBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Seminars in Oncology Nursing is a quarterly journal for the dissemination of knowledge in the complex field of cancer nursing. The Journal contains topical reviews carefully prepared by selected experts. Each issue focuses on a specific topic, with the aim of comprehensive coverage.2013 Forthcoming Issue - Volume 29, Issues 4November: Cognitive Changes Associated with Cancer and Cancer Treatment2014 Forthcoming Topics - Volume 30, Issues 1-4February: Advanced Nursing Science Within the Cooperative Group SettingMay: Personalizing Patient Care with Precision MedicineAugust: Targeted TherapiesNovember: TBABenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.Seminars in Radiation Oncology has an Impact Factor of 4.312 and is ranked 10th of 90 journals in Radiology, Nuclear Medicine & Medical Imaging category and 38th of 141 in Oncology category on the 2009 Journal Citation Reports®, published by Thomson Reuters.2011 Topics: Volume 21, Issues 1-4JanuaryEarly Stage Breast CancerLori Pierce, MDAprilMetabolic and Functional Imaging with Radiation TherapyJames M. Balter, PhDJulyRectal CancerBrian Czito, MD, and Christopher Willett, MDOctoberLiver Tumors (primary and metastatic)Laura Dawson, MD

STEM CELLS, a peer-reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.

STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cell research including embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

'Supportive Care in Cancer' provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. The journal primarily covers medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease. Nursing, rehabilitative, psychosocial and spiritual issues of support is also covered.

Surgical Oncology's 2012 Impact Factor is 2.136 (© Thomson Reuters Journal Citation Reports 2013).Surgical Oncology is a peer reviewed journal publishing reviews, systematic reviews and meta-analyses that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive reviews which examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Surgical Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in surgical oncology, including pancreatic cancer, radiation oncology, breast cancer, colorectal cancer, head and neck cancer, palliative care, gene therapy, sarcomas, cancer screening, treatment of colorectal cancer, biliary tract and primary liver tumors, breast cancer, imaging, and more.Surgical Oncology Clinics of North America is published for times each year, in January, April, July, and October.